(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

INTRINSEQUE HEALTH

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

INTRINSEQUE HEALTH

ST13

US500000098600677

Classe

35, 39, 42

Pedido

98600677

Registro

8034422

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

23

Atualização mais recente

19/11/2025

Tipo de marca

Verbal

Classes Nice

35, 39, 42

Data de depósito

13/06/2024

Data de registro

18/11/2025

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

18/11/2025

Última transação

19/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

08/04/2020

Primeiro uso no comércio

04/08/2020

Código do desenho

4

Tipo de titular

99

Localização do titular

Singapore, SG

Examinador

DIBLE,JONATHON I

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

INTRINSEQUE HEALTH PTE. LTD.

Representantes

Elias Hantula

Classificação técnica

Classes Nice

Classe 35Classe 39Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Advisory services relating to business management and business operations; Assistanceadvisory services and consultancy with regard to business planning; Business auditing; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting and management in the field of clinical trialsproviding information management services; Business consulting services relating to product distributionoperations management serviceslogisticsreverse logisticssupply chainproduction systems and distribution solutions; Business organization and operation consultancy; Business project management services; Business strategic planning services; Computerized file management; Consultation in the field of procurement of goods and services; Database management services; Inventory control; Inventory management; Outsourcing services in the nature of arranging procurement of goods for others; Personnel recruitment; Professional staffing services; Providing trade information

Classe 39

Advisory services relating to transport; Delivery of goods; Rental of storage containers; Storage of goods; Transport of goods; Transportation and storage of goods in refrigerated conditions; Warehouse storage

Classe 42

Biological research; Calibration services; Calibration; Chemical research services; Consulting services for others in the field of designplanningimplementation project management of scientific research and clinical trials; Medical research laboratory services; Pharmaceutical research services; Providing medical and scientific research information in the field of clinical trials; Research and development services of new pharmaceutical products

Publicações

Histórico de despachos e eventos da marca no USPTO.

23 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

18/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

18/11/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

29/10/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

29/10/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

24/09/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

23/09/2025

IUAF

USE AMENDMENT FILED

29/04/2025

EISU

TEAS STATEMENT OF USE RECEIVED

29/04/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/02/2025

PUBO

PUBLISHED FOR OPPOSITION

04/02/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

29/01/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/01/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

10/01/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/01/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

10/01/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/01/2025

DOCK

ASSIGNED TO EXAMINER

06/01/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/01/2025

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

08/10/2024

ALIE

ASSIGNED TO LIE

08/10/2024

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

20/06/2024

NWAP

NEW APPLICATION ENTERED

14/06/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace INTRINSEQUE HEALTH ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.